RESUMEN
This study's objectives were to test correlations among groups of biomarkers that are associated with condylar morphology and to apply artificial intelligence to test shape analysis features in a neural network (NN) to stage condylar morphology in temporomandibular joint osteoarthritis (TMJOA). Seventeen TMJOA patients (39.9 ± 11.7 y) experiencing signs and symptoms of the disease for less than 10 y and 17 age- and sex-matched control subjects (39.4 ± 15.2 y) completed a questionnaire, had a temporomandibular joint clinical exam, had blood and saliva samples drawn, and had high-resolution cone beam computed tomography scans taken. Serum and salivary levels of 17 inflammatory biomarkers were quantified using protein microarrays. A NN was trained with 259 other condyles to detect and classify the stage of TMJOA and then compared to repeated clinical experts' classifications. Levels of the salivary biomarkers MMP-3, VE-cadherin, 6Ckine, and PAI-1 were correlated to each other in TMJOA patients and were significantly correlated with condylar morphological variability on the posterior surface of the condyle. In serum, VE-cadherin and VEGF were correlated with one another and with significant morphological variability on the anterior surface of the condyle, while MMP-3 and CXCL16 presented statistically significant associations with variability on the anterior surface, lateral pole, and superior-posterior surface of the condyle. The range of mouth opening variables were the clinical markers with the most significant associations with morphological variability at the medial and lateral condylar poles. The repeated clinician consensus classification had 97.8% agreement on degree of degeneration within 1 group difference. Predictive analytics of the NN's staging of TMJOA compared to the repeated clinicians' consensus revealed 73.5% and 91.2% accuracy. This study demonstrated significant correlations among variations in protein expression levels, clinical symptoms, and condylar surface morphology. The results suggest that 3-dimensional variability in TMJOA condylar morphology can be comprehensively phenotyped by the NN.
Asunto(s)
Inteligencia Artificial , Tomografía Computarizada de Haz Cónico , Osteoartritis/diagnóstico , Trastornos de la Articulación Temporomandibular/diagnóstico , Adulto , Biomarcadores/análisis , Estudios de Casos y Controles , Humanos , Persona de Mediana Edad , Articulación Temporomandibular/diagnóstico por imagen , Articulación Temporomandibular/fisiopatologíaRESUMEN
With the introduction of the on-line preparation of dialysis fluids, the hemofiltration technique, which has never had a widespread diffusion in its old version with the infusion bags, has gained a new interest. We planned a prospective, randomized, 3-year-long study comparing survival and morbidity in ultrapure bicarbonate dialysis (BD) with on-line predilution hemofiltration (HF). Since comorbidity is one of the main factors limiting survival, the study was addressed to patients with a severe degree of comorbidity. The paper presents the preliminary results of the trial. Sixty-four patients were enrolled and randomized to either BD (N = 32) or HF (N = 32). Mean age and dialysis vintage were comparable. Twenty patients died during the study, 12 in BD and 8 in HF. The relative risk of death was 11% higher in patients treated with BD compared to those in the HF group (p < 0.005). The number of hospitalisation events per single patient was lower, even though not significantly, in HF compared to BD (1.94 + 1.26 in HF vs 2.48 + 1.98 in BD, p = NS). As concerns biochemistry, apart from beta-2-microglobulin, any other substantial difference was not found during the study, though the small solute concentration was generally a little more elevated in HF than in BD. Dialysis hypotension showed a trend to decrease in both the dialysis modalities up to near half of the trial, then, during the last year, it remained quite stable in HF, while, on the contrary, it increased in the BD group. By the end of the protocol, patients in HF showed a 2.5% incidence of acute dialysis hypotension, while patients in BD had 23%.
Asunto(s)
Bicarbonatos/uso terapéutico , Hemofiltración/métodos , Diálisis Renal , Anciano , Sangre/metabolismo , Hemodinámica , Hospitalización/estadística & datos numéricos , Humanos , Persona de Mediana Edad , Morbilidad , Análisis de Supervivencia , Microglobulina beta-2/sangreRESUMEN
The surgical treatment of liver metastasis due to colorectal cancer can substantially modify the natural history of the disease, mainly when it is associated with effective medical treatment. Chemotherapy, via systemic or locoregional (intrahepatic) administration, has 2 possible objectives: as adjuvant treatment, to prevent or delay disease recurrence; as neo-adjuvant treatment, mainly interesting for the surgeon, to allow resective surgery in responding patients previously considered not-operable. Unfortunately, the severe immune deficiency associated with the advanced cancer negative impact on long-term outcome after any treatment (surgery, chemotherapy) is a limit for the clinical application of multidisciplinary treatments. Aim of this study is to review the possible different approaches to improve the clinical results, either as tumour response or overall survival, using an association of IL-2 with different chemotherapy procedures, in order to recover the locoregional and/or systemic immunodeficency. Several literature studies are worth of consideration not only for the biological activity reported, but also for the preliminary clinical results. At our Department, we have started a clinical experience in order to verify and confirm the results reported in these studies. The preliminary results seem to confirm an increase of chemotherapy activity obtained with an association of IL-2 immunotherapy with systemic therapy procedures and mainly with locoregional therapeutic programs.
Asunto(s)
Adenocarcinoma/secundario , Adenocarcinoma/cirugía , Antineoplásicos/uso terapéutico , Neoplasias del Colon , Inmunoterapia , Interleucina-2/uso terapéutico , Neoplasias Hepáticas/secundario , Neoplasias Hepáticas/cirugía , Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/inmunología , Adenocarcinoma/mortalidad , Antimetabolitos Antineoplásicos/administración & dosificación , Antimetabolitos Antineoplásicos/uso terapéutico , Antineoplásicos/administración & dosificación , Terapia Combinada , Fluorouracilo/administración & dosificación , Fluorouracilo/uso terapéutico , Estudios de Seguimiento , Arteria Hepática , Humanos , Infusiones Intraarteriales , Inyecciones Subcutáneas , Interleucina-2/administración & dosificación , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Hepáticas/inmunología , Neoplasias Hepáticas/mortalidad , Cuidados Posoperatorios , Cuidados Preoperatorios , Ensayos Clínicos Controlados Aleatorios como Asunto , Factores de TiempoAsunto(s)
Corticoesteroides/uso terapéutico , Antioxidantes/uso terapéutico , Depuradores de Radicales Libres/uso terapéutico , Peroxidación de Lípido/efectos de los fármacos , Insuficiencia Multiorgánica/tratamiento farmacológico , Pregnatrienos/uso terapéutico , Animales , Antiinflamatorios/uso terapéutico , Ensayos Clínicos como Asunto , Humanos , Inyecciones Intraperitoneales , Metilprednisolona/uso terapéutico , Insuficiencia Multiorgánica/mortalidad , Estudios Prospectivos , Conejos , Ensayos Clínicos Controlados Aleatorios como Asunto , Síndrome de Dificultad Respiratoria/tratamiento farmacológico , Sepsis/tratamiento farmacológico , Choque Séptico/tratamiento farmacológico , Zimosan/administración & dosificaciónAsunto(s)
Complemento C3a/análogos & derivados , Sepsis/fisiopatología , Proteínas de Fase Aguda/sangre , Aminoácidos/sangre , Anafilatoxinas/sangre , Arterias , Biomarcadores , Complemento C3/análogos & derivados , Complemento C3/metabolismo , Endotoxinas/sangre , Humanos , Orosomucoide/metabolismo , Oxígeno/sangre , Consumo de Oxígeno , Elastasa Pancreática/sangre , Pronóstico , VenasRESUMEN
Endotoxemia without sepsis was detected with a chromogenic Limulus assay in 36 of 39 (92.3%) cirrhotic patients and was absent in seven healthy volunteers. In 11 patients who underwent elective portasystemic shunt, portal vein endotoxemia was higher than inferior vena caval: p less than 0.05, systemic endotoxin levels did not change, compared to preoperative levels, on the 1st, 2nd, and 3rd postoperative days, attendant to an uneventful recovery. In 21 patients in hepatic encephalopathy after esophagogastric hemorrhage, systemic endotoxemia was higher than in well-compensated cirrhotics: p less than 0.001; it was higher in deep than in light coma: p less than 0.05; it was higher in those who died than in those who survived: p less than 0.001. Endotoxin levels showed a positive correlation with serum bilirubin: r = 0.59, p less than 0.001, and a negative correlation with prothrombin activity: r = -0.59, p less than 0.001. These data show endotoxemia without sepsis is a constant finding in cirrhosis and increasing levels of endotoxemia are associated with hepatic failure, encephalopathy, and death.
Asunto(s)
Endotoxinas/sangre , Encefalopatía Hepática/sangre , Cirrosis Hepática/sangre , Adulto , Anciano , Femenino , Encefalopatía Hepática/microbiología , Humanos , Prueba de Limulus , Cirrosis Hepática/microbiología , Cirrosis Hepática/mortalidad , Cirrosis Hepática/cirugía , Masculino , Persona de Mediana Edad , Periodo Posoperatorio , Sepsis/diagnósticoRESUMEN
Conflicting results concerning the affiliative personality of firstborns and later borns can be explained by considering the importance of the birth of a sibling and the age spacing between the siblings. It is particularly important to determine whether the sibling was born before or after the firstborn was 3 years old, since this age represents the period during which his individuation-separation process is completed. The birth of a sibling before this age would give rise to affiliation and succorance needs, which we propose to consider together under the name of "symbiotic dependence." Comparisons between the responses to the Edwards Personal Preference Schedule given by 32 pairs of firstborns, 17-19 years old, revealed that firstborns having siblings less than 3 years younger show greater affiliation and succorance needs than firstborns not having close siblings.